John Overdeck’s Hewlett Packard Enterprise 7.625% Series C Preferred Stock HPE.PRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Sell
179,126
-1,158,559
-87% -$110M 0.02% 1032
2026
Q1
$86.3M Buy
1,337,685
+1,046,324
+359% +$64.2M 0.07% 316
2025
Q4
$19.4M Buy
291,361
+4,041
+1% +$264K 0.03% 742
2025
Q3
$19.5M Buy
287,320
+149,069
+108% +$9.36M 0.03% 646
2025
Q2
$8.14M Buy
138,251
+20,051
+17% +$1.01M 0.01% 936
2025
Q1
$5.64M Sell
118,200
-457,353
-79% -$26.7M 0.01% 1060
2024
Q4
$36.1M Buy
575,553
+204,253
+55% +$12.6M 0.08% 315
2024
Q3
$22.5M Buy
+371,300
New +$21.8M 0.05% 445

Other funds holding HPE.PRC

John Overdeck's HPE.PRC Position: Q2 2026 in Review

John Overdeck reduced its Hewlett Packard Enterprise 7.625% Series C Preferred Stock (HPE.PRC) stake by 87% in Q2 2026, selling an estimated $110M and leaving 179,126 shares worth $20.7M. The position accounts for 0.02% of the portfolio, ranked #1032.

John Overdeck first reported a position in HPE.PRC in Q3 2024 and has held it in 8 quarters since. The position peaked at $86.3M in Q1 2026. 93 funds tracked by Wall St. Rank hold HPE.PRC as of Q2 2026.

  • John Overdeck held 179,126 shares of Hewlett Packard Enterprise 7.625% Series C Preferred Stock worth $20.7M as of Q2 2026.
  • John Overdeck sold 1,158,559 Hewlett Packard Enterprise 7.625% Series C Preferred Stock shares in Q2 2026, an estimated $110M.
  • Hewlett Packard Enterprise 7.625% Series C Preferred Stock made up 0.02% of John Overdeck's portfolio in Q2 2026, its #1032 holding.
  • John Overdeck first reported a position in Hewlett Packard Enterprise 7.625% Series C Preferred Stock in Q3 2024 and has held it in 8 quarters since.
  • John Overdeck's Hewlett Packard Enterprise 7.625% Series C Preferred Stock position peaked at $86.3M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Hewlett Packard Enterprise 7.625% Series C Preferred Stock as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.